Plunkett Research Online: Erytech Pharma

ERYTECH PHARMA (ERYP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Erytech Pharma develops therapeutics in the field of cancer. The Company's proprietary technology is based on encapsulation of therapeutic molecules into red blood cells. It develops ERY-ASP that consists of red blood cell-encapsulated L-asparaginase and is in Phase III trial in Europe and in Phase .....



Erytech Pharma
Ticker: ERYP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 478744438
Fax: 33 478755629
Address: 60 Avenue Rockefeller
Batiment Adenine
Lyon, 69008 France

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

Erytech Pharma develops therapeutics in the field of cancer. The Company's proprietary technology is based on encapsulation of therapeutic molecules into red blood cells. It develops ERY-ASP that consists of red blood cell-encapsulated L-asparaginase and is in Phase III trial in Europe and in Phase .....See More See More

Auditor: KPMG S.A.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: